| Chiang CY |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=2.035 ------>paper_class3=2 ------>paper_class2=1 ------>vol=12 ------>confirm_bywho=chshih43 ------>insert_bywho=bkj ------>Jurnal_Rank=52.9 ------>authors4_c= ------>comm_author= ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2=446 ------>medlineContent= ------>unit=E0400 ------>insert_date=20080404 ------>iam=3 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=500 ------>journal_name=Int J Tuberc Lung Dis ------>paper_name=Factors associated with a clinician's decision to stop anti-tuberculosis treatment before completion ------>confirm_date=20080507 ------>tch_id=089122 ------>pmid=18371272 ------>page1=441 ------>fullAbstract=OBJECTIVES: To investigate the diagnosis of pulmonary tuberculosis (PTB) and factors associated with a clinician~s decision to stop anti-tuberculosis treatment before completion. DESIGN: The medical charts of all citizens of Taipei City, Taiwan, reported to have received treatment for PTB in 2003 were investigated. RESULTS: Of 1126 PTB patients, 512 (45.5%) started treatment immediately based solely on chest X-ray (CXR) findings; treatment for 214 (19.0%) was based on a positive sputum smear for acid-fast bacilli, for 261 (23.2%) it was based on other findings and for 139 (12.3%) it was based on a positive mycobacterial culture. Of the 1126 PTB patients, 156 (13.9%) had their diagnosis of TB changed by a clinician. Multivariate analysis shows that patients whose diagnosis was based on CXR or other findings, female patients, patients who interrupted treatment for 2 months, patients who continued care at other health facilities (transfer) and patients with lung cancer were significantly more likely to have their diagnosis changed than other groups. CONCLUSION: A substantial proportion of patients were prescribed anti-tuberculosis treatment based on CXR findings alone, and a considerable proportion were advised to stop treatment before completing a full course, findings that require the immediate attention of Taiwan~s National Tuberculosis Programme. ------>tmu_sno=None ------>sno=17458 ------>authors2=Enarson DA ------>authors3=Bai KJ ------>authors4=Suo J ------>authors5=Wu YC ------>authors6=Lin TP, Luh KT ------>authors6_c= ------>authors=Chiang CY ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=Factors associated with a clinician~s decision to stop anti-tuberculosis treatment before completion. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=4 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2008 ------>submit_flag=None ------>publish_month=4 |